Furthermore, this study investigated the relationship between RPS6KA2 expression and key signaling pathways associated with cell proliferation (Fig. 1H) and apoptosis (Fig. 1I) in ovarian cancer. Here, RPS6KA2 is linked to ovarian cancer.